Susquehanna International Group
PGNX

Susquehanna International Group’s Progenics Pharmaceuticals Inc PGNX Stock Holding History

Susquehanna International Group’s Portfolio PGNX Stock Details PGNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-27,000
Closed -$103K – 11412
2020
Q1 		$103K Sell
27,000
-49,900
-65% -$215K ﹤0.01% 9310
2019
Q4 		$391K Buy
76,900
+51,500
+203% +$272K ﹤0.01% 7475
2019
Q3 		$128K Sell
25,400
-8,500
-25% -$42.4K ﹤0.01% 9427
2019
Q2 		$209K Buy
33,900
+18,200
+116% +$87.7K ﹤0.01% 9059
2019
Q1 		$73K Sell
15,700
-283,300
-95% -$1.28M ﹤0.01% 8369
2018
Q4 		$1.26M Sell
299,000
-99,200
-25% -$505K ﹤0.01% 4272
2018
Q3 		$2.5M Sell
398,200
-10,800
-3% -$83K ﹤0.01% 3641
2018
Q2 		$3.29M Sell
409,000
-716,500
-64% -$5.47M ﹤0.01% 3269
2018
Q1 		$8.4M Buy
1,125,500
+965,300
+603% +$6.42M ﹤0.01% 1965
2017
Q4 		$953K Sell
160,200
-11,800
-7% -$71.7K ﹤0.01% 5334
2017
Q3 		$1.27M Buy
172,000
+63,100
+58% +$401K ﹤0.01% 4832
2017
Q2 		$739K Buy
108,900
+10,300
+10% +$76K ﹤0.01% 5898
2017
Q1 		$931K Buy
98,600
+39,600
+67% +$395K ﹤0.01% 5274
2016
Q4 		$510K Buy
59,000
+45,100
+324% +$333K ﹤0.01% 6964
2016
Q3 		$88K Sell
13,900
-20,400
-59% -$123K ﹤0.01% 7990
2016
Q2 		$145K Sell
34,300
-74,400
-68% -$359K ﹤0.01% 7842
2016
Q1 		$474K Buy
108,700
+44,500
+69% +$198K ﹤0.01% 6501
2015
Q4 		$394K Buy
64,200
+20,700
+48% +$136K ﹤0.01% 7215
2015
Q3 		$249K Sell
43,500
-6,500
-13% -$49.9K ﹤0.01% 8349
2015
Q2 		$373K Sell
50,000
-140,800
-74% -$852K ﹤0.01% 8161
2015
Q1 		$1.14M Buy
190,800
+78,100
+69% +$492K ﹤0.01% 5481
2014
Q4 		$852K Sell
112,700
-88,300
-44% -$528K ﹤0.01% 6177
2014
Q3 		$1.04M Buy
201,000
+51,200
+34% +$255K ﹤0.01% 5834
2014
Q2 		$646K Sell
149,800
-58,900
-28% -$225K ﹤0.01% 6971
2014
Q1 		$854K Buy
208,700
+104,500
+100% +$534K ﹤0.01% 5784
2013
Q4 		$555K Buy
104,200
+38,100
+58% +$168K ﹤0.01% 6529
2013
Q3 		$332K Buy
66,100
+31,600
+92% +$171K ﹤0.01% 7067
2013
Q2 		$154K Buy
+34,500
New +$155K ﹤0.01% 7620

Other funds holding PGNX

ECM
Everence Capital Management Goshen, Indiana $1.9B AUM 39.77% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return
Daiwa Securities Group
Daiwa Securities Group Tokyo, Japan $51.1B AUM 35.55% 1-Year Est. Return

Susquehanna International Group's PGNX Position: Q2 2020 in Review

Susquehanna International Group sold out of Progenics Pharmaceuticals Inc (PGNX) in Q2 2020, closing a stake of 65,909 shares — an estimated $250K sold.

Susquehanna International Group first reported a position in PGNX in Q3 2013 and held it in 24 quarters. The position peaked at $2.89M in Q1 2018. 3 funds tracked by Wall St. Rank hold PGNX as of Q2 2020.

  • Susquehanna International Group reported no remaining Progenics Pharmaceuticals Inc position as of Q2 2020 after selling out during the quarter.
  • Susquehanna International Group sold 65,909 Progenics Pharmaceuticals Inc shares in Q2 2020, an estimated $250K.
  • Susquehanna International Group first reported a position in Progenics Pharmaceuticals Inc in Q3 2013 and held it in 24 quarters.
  • Susquehanna International Group's Progenics Pharmaceuticals Inc position peaked at $2.89M in Q1 2018.
  • 3 funds tracked by Wall St. Rank held Progenics Pharmaceuticals Inc as of Q2 2020.

Based on Susquehanna International Group's 13F filing for Q2 2020, filed 14 Aug 2020.